Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Manage episode 505871825 series 3393216
Content provided by Baptist Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Baptist Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Why do thyroid cancers demand a more nuanced approach, despite high survival rates?
In this episode of Doc to Doc, Dr. Meghan Crawley, head and neck surgical oncologist at Miami Cancer Institute, joins Dr. Rachel Slotcavage, endocrine surgeon at Lynn Cancer Institute, to explore what makes thyroid cancers so unique and how treatment approaches are evolving.
From surgery and RAI therapy to targeted therapies, immunotherapy, and biomarker-driven decisions, this conversation takes a closer look at how precision medicine is shaping the future of thyroid cancer care—and what every clinician should consider in today’s multidisciplinary landscape.
Meghan Crawley, M.D.
Head and Neck Surgical Oncologist with Baptist Health Miami Cancer Institute
Rachel Slotcavage, M.D.
Endocrine surgeon with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital
33 episodes
